Stock listing

Cboe Canada:TRIP Rhelion Life Sciences Corp. Stock

Canadian listing (Cboe Canada) of Rhelion Life Sciences Corp. · home listing CSE:RHEL

Follow Rhelion Life Sciences Corp. into a list and get an email when it puts out news.

Home listing price · CSE:RHEL

$0.025 CAD 0.000 (0.0%)

Close on Oct 21, 2026 · This listing has no price on 6ix; the price shown is the home listing's, CSE:RHEL · Data provided by Twelve Data

Past month 0.0% · daily closes, Aug 4, 2026 – Oct 21, 2026, adjusted for splits

Day range: $0.025 – $0.025 CADOct 21, 2026
Volume: 96,001 sharesOct 21, 2026
Market cap: $15.35M CADAt the close on Oct 21, 2026 · price × 614.1M shares outstanding

Prices by listing

Listing	Last	Change	Volume	Open	High	Low	Previous close	Price from
CSE:RHEL · Home	$0.025 CAD	0.000 (0.0%)	96,001	$0.025	$0.025	$0.025	$0.025	Close on Oct 21, 2026
OTC:TRUFF	$0.018 USD	+0.001 (+3.5%)	42,500	$0.018	$0.018	$0.018	$0.017	Close on Oct 19, 2026

Data provided by Twelve Data

Daily closes

Last 3 months, Aug 4, 2026 – Oct 21, 2026 · CSE:RHEL · CAD, adjusted for splits

Day	Close	Change	%	Open	High	Low	Volume
Wed, Oct 21	$0.025	0.000	0.0%	$0.025	$0.025	$0.025	96,001
Tue, Oct 20	$0.025	0.000	0.0%	$0.025	$0.025	$0.020	17,600
Mon, Oct 19	$0.025	0.000	0.0%	$0.020	$0.025	$0.020	63,000
Fri, Oct 16	$0.025	0.000	0.0%	$0.025	$0.025	$0.020	171,070
Thu, Oct 15	$0.025	0.000	0.0%	$0.030	$0.030	$0.025	106,660
Wed, Oct 14	$0.025	0.000	0.0%	$0.025	$0.025	$0.025	111,544
Tue, Oct 13	$0.025	0.000	0.0%	$0.025	$0.025	$0.025	54,553
Fri, Oct 9	$0.025	0.000	0.0%	$0.025	$0.025	$0.025	507,150
Thu, Oct 8	$0.025	0.000	0.0%	$0.025	$0.025	$0.025	104,000
Wed, Oct 7	$0.025	0.000	0.0%	$0.030	$0.030	$0.025	11,000
Tue, Oct 6	$0.025	0.000	0.0%	$0.025	$0.025	$0.025	136,000
Mon, Oct 5	$0.025	0.000	0.0%	$0.025	$0.025	$0.025	65,300
Fri, Oct 2	$0.025	-0.005	-16.7%	$0.030	$0.030	$0.025	1,483,733
Thu, Oct 1	$0.030	0.000	0.0%	$0.030	$0.030	$0.030	151,000
Wed, Sep 30	$0.030	0.000	0.0%	$0.025	$0.030	$0.025	69,256
Tue, Sep 29	$0.030	0.000	0.0%	$0.030	$0.030	$0.030	22,000
Mon, Sep 28	$0.030	-0.005	-14.3%	$0.030	$0.030	$0.030	384,892
Fri, Sep 25	$0.035	+0.005	+16.7%	$0.030	$0.035	$0.030	419,257
Thu, Sep 24	$0.030	-0.005	-14.3%	$0.035	$0.035	$0.030	65,570
Wed, Sep 23	$0.035	0.000	0.0%	$0.030	$0.035	$0.030	62,029
Tue, Sep 22	$0.035	+0.003	+7.7%	$0.035	$0.035	$0.030	388,200
Mon, Sep 21	$0.032	+0.003	+8.3%	$0.030	$0.035	$0.030	127,130
Fri, Sep 18	$0.030	-0.003	-7.7%	$0.030	$0.030	$0.030	209,750
Thu, Sep 17	$0.032	+0.003	+8.3%	$0.035	$0.035	$0.030	130,014
Wed, Sep 16	$0.030	0.000	0.0%	$0.035	$0.035	$0.030	132,900
Tue, Sep 15	$0.030	-0.003	-7.7%	$0.030	$0.030	$0.030	160,301
Mon, Sep 14	$0.032	0.000	0.0%	$0.032	$0.032	$0.032	0
Fri, Sep 11	$0.032	+0.003	+8.3%	$0.032	$0.032	$0.030	218,000
Thu, Sep 10	$0.030	-0.005	-14.3%	$0.030	$0.032	$0.030	241,690
Wed, Sep 9	$0.035	+0.005	+16.7%	$0.030	$0.035	$0.030	502,650
Tue, Sep 8	$0.030	0.000	0.0%	$0.030	$0.030	$0.030	542,701
Fri, Sep 4	$0.030	0.000	0.0%	$0.025	$0.030	$0.025	20,830
Thu, Sep 3	$0.030	0.000	0.0%	$0.030	$0.030	$0.030	133,942
Wed, Sep 2	$0.030	0.000	0.0%	$0.035	$0.035	$0.030	107,000
Tue, Sep 1	$0.030	0.000	0.0%	$0.035	$0.035	$0.030	697,766
Mon, Aug 31	$0.030	+0.005	+20.0%	$0.025	$0.030	$0.025	658,077
Fri, Aug 28	$0.025	-0.005	-16.7%	$0.030	$0.035	$0.025	78,048
Thu, Aug 27	$0.030	+0.005	+20.0%	$0.030	$0.030	$0.025	346,050
Wed, Aug 26	$0.025	-0.005	-16.7%	$0.025	$0.025	$0.025	35,365
Tue, Aug 25	$0.030	0.000	0.0%	$0.030	$0.030	$0.030	25,357
Mon, Aug 24	$0.030	0.000	0.0%	$0.030	$0.030	$0.025	118,501
Fri, Aug 21	$0.030	+0.005	+20.0%	$0.025	$0.030	$0.025	84,100
Thu, Aug 20	$0.025	0.000	0.0%	$0.025	$0.030	$0.025	109,922
Wed, Aug 19	$0.025	0.000	0.0%	$0.030	$0.030	$0.025	81,000
Tue, Aug 18	$0.025	-0.005	-16.7%	$0.025	$0.025	$0.025	32,320
Mon, Aug 17	$0.030	0.000	0.0%	$0.030	$0.030	$0.030	229,894
Fri, Aug 14	$0.030	+0.005	+20.0%	$0.030	$0.030	$0.025	209,940
Thu, Aug 13	$0.025	-0.005	-16.7%	$0.030	$0.035	$0.025	216,599
Wed, Aug 12	$0.030	+0.005	+20.0%	$0.030	$0.035	$0.030	382,570
Tue, Aug 11	$0.025	0.000	0.0%	$0.025	$0.030	$0.025	18,298
Mon, Aug 10	$0.025	-0.005	-16.7%	$0.025	$0.030	$0.025	223,403
Fri, Aug 7	$0.030	0.000	0.0%	$0.030	$0.030	$0.030	12,500
Thu, Aug 6	$0.030	+0.005	+20.0%	$0.035	$0.035	$0.025	97,900
Wed, Aug 5	$0.025	0.000	0.0%	$0.040	$0.040	$0.025	78,159
Tue, Aug 4	$0.025	—	—	$0.030	$0.032	$0.025	30,000

Ticker: Cboe Canada:TRIP
Asset type: Stock
Sector: Health care
Industry: Biotechnology
Exchange: Cboe Canada
Currency: CAD

What changed lately

Latest news release · Oct 16, 2026
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health to Supply Belgium's First Psilocybin Compassionate Use Program, to Help Open the Door to Patient Access for Treatment-Resistant Depression

Latest news

Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health to Supply Belgium's First Psilocybin Compassionate Use Program, to Help Open the Door to Patient Access for Treatment-Resistant Depression

Oct 16, 2026

Closed $0.025 (0.0%) on Oct 16, 2026

Rhelion Life Sciences Reappoints Dr. Robin Carhart-Harris as Scientific Advisor

Oct 14, 2026

Closed $0.025 (0.0%) on Oct 14, 2026

Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Licence Agreement with the University of California, San Francisco for a Phase 2 Trial of Psilocybin in Methamphetamine Use Disorder Among People with HIV

Oct 8, 2026

Closed $0.025 (0.0%) on Oct 8, 2026

Tripadvisor Announces 2026 Travelers' Choice Awards: Best of the Best Restaurants, Showcasing the World's Top Eateries & Experiences

Sep 15, 2026

Closed $0.03 (-7.7%) on Sep 15, 2026

Issued by another party

Red Light Holland Reports Fiscal 2026 Audited Year-End Results and Provides Update on Rhelion Life Sciences

Jul 29, 2026

Red Light Holland Announces New Filament Health PEX010 European Research Shipment

Jul 16, 2026

Red Light Holland Announces Filament Health's Largest-Ever Manufacturing Run of PEX010, the Standardized and Patented Natural Psilocybin Drug Candidate Trusted Across 80+ Studies Globally, Now Offering the Widest Standardized Dosing Range, from 0.5 mg to 25 mg

Jul 8, 2026

Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Military Veterans PTSD Study at ARQ National Psychotrauma Centre

Jul 7, 2026

Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filament Health

Jun 18, 2026

American Express Announces Proposed Acquisition of TheFork, a Leading European Restaurant Booking Platform

Jun 15, 2026

All Rhelion Life Sciences Corp. news

Decks

Red Light Holland — Investor Presentation (December 2024)
Investor deck · 30 slides · December 2024
Red Light Holland — Investor Presentation (September 2022)
Investor deck · 24 slides · September 2022

Rhelion Life Sciences Corp. on 6ix

Sector: Health care
Industry: Biotechnology
News releases: 52 in the last 12 months · 138 in all · newest Oct 16, 2026 · oldest 2012
Decks: 2 decks · latest December 2024

Where Rhelion Life Sciences Corp. is listed

Listing	Exchange	Country	Currency
CSE:RHEL · Home listing	CSE	Canada	CAD
OTC:TRUFF	OTC	United States	USD
Cboe Canada:TRIP · This page	Cboe Canada	Canada	CAD
Frankfurt:4YX	Frankfurt	Germany	EUR
LS Exchange:A2P5KA	LS Exchange	Germany	EUR
gettex:4YX	gettex	Germany	EUR
Lang & Schwarz:A2P5KA	Lang & Schwarz	Germany	EUR
Stuttgart:4YX	Stuttgart	Germany	EUR
Munich:4YX	Munich	Germany	EUR

Cboe Canada:TRIP Rhelion Life Sciences Corp. Stock

Prices by listing

Daily closes

What changed lately

Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health to Supply Belgium's First Psilocybin Compassionate Use Program, to Help Open the Door to Patient Access for Treatment-Resistant Depression

Latest news

Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health to Supply Belgium's First Psilocybin Compassionate Use Program, to Help Open the Door to Patient Access for Treatment-Resistant Depression

Rhelion Life Sciences Reappoints Dr. Robin Carhart-Harris as Scientific Advisor

Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Licence Agreement with the University of California, San Francisco for a Phase 2 Trial of Psilocybin in Methamphetamine Use Disorder Among People with HIV

Tripadvisor Announces 2026 Travelers' Choice Awards: Best of the Best Restaurants, Showcasing the World's Top Eateries & Experiences

Red Light Holland Reports Fiscal 2026 Audited Year-End Results and Provides Update on Rhelion Life Sciences

Red Light Holland Announces New Filament Health PEX010 European Research Shipment

Red Light Holland Announces Filament Health's Largest-Ever Manufacturing Run of PEX010, the Standardized and Patented Natural Psilocybin Drug Candidate Trusted Across 80+ Studies Globally, Now Offering the Widest Standardized Dosing Range, from 0.5 mg to 25 mg

Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Military Veterans PTSD Study at ARQ National Psychotrauma Centre

Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filament Health

American Express Announces Proposed Acquisition of TheFork, a Leading European Restaurant Booking Platform

Decks

Red Light Holland — Investor Presentation (December 2024)

Red Light Holland — Investor Presentation (September 2022)

Rhelion Life Sciences Corp. on 6ix

Where Rhelion Life Sciences Corp. is listed